-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvilostomig in Gastrointestinal Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvilostomig in Gastrointestinal Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvilostomig in Gastrointestinal Tumor Drug Details: Danvilostomig (SIB-003) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvilostomig in Nasopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvilostomig in Nasopharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvilostomig in Nasopharyngeal Cancer Drug Details: Danvilostomig (SIB-003) is under development...
-
Thematic Analysis
NewCybersecurity in Automotive – Thematic Intelligence
Cybersecurity in Automotive Thematic Report Overview Cybersecurity is crucial for all automotive businesses to prevent hackers from compromising the safety and advanced driver assistance systems (ADAS) of a vehicle in use or, worse, manipulating any autonomous functionality to directly cause a crash. At a higher level, automotive companies are also at risk of industrial cybercrime, such as the theft of valuable tech secrets or damage to their digital infrastructure. The ‘Cybersecurity in Automotive’ thematic intelligence report provides insights into the...
-
Thematic Analysis
NewCybersecurity – Thematic Intelligence
Cybersecurity Thematic Intelligence Report Overview The prospect of offensive attacks using artificial intelligence (AI) is prompting an increase in cybersecurity budgets as organizations try to understand the impact of generative AI on their security. Both start-ups and maturing cyber companies will be on the radar of larger cybersecurity companies looking for products and talent. Moreover, cybersecurity M&A will be a strong focus during 2024 as a small group of private equity players are buying up numerous cybersecurity companies. Buy the...
-
Thematic Analysis
NewCybersecurity in Sport – Thematic Intelligence
No company is safe from cyberattacks, but sports organizations are more vulnerable than most. The business of sport naturally accrues a large amount of sensitive data, from fans’ personal data to performance data on athletes. The UK National Cyber Security Centre survey found that more than 70% of sports organizations had experienced a cybersecurity breach, more than double the UK average. Sports teams, federations, broadcasters, and sponsors are all vulnerable to attacks due to their significant revenues, the exposure any...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acimtamig in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acimtamig in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acimtamig in B-Cell Non-Hodgkin Lymphoma Drug Details: AFM-13 is under development...
-
Sector Analysis
NewOnline Travel Market Trends and Analysis by Service Type, Region and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Online Travel’ report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Online...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvilostomig in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvilostomig in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvilostomig in Head And Neck Squamous Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvilostomig in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvilostomig in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvilostomig in Hypopharyngeal Cancer Drug Details: Danvilostomig (SIB-003) is under development for...